BlackRock Institutional Trust’s Filana Therapeutics FLNA Stock Holding History

BlackRock Institutional Trust’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$800K	Buy	200,380 +15,086	+8%	+$70K	﹤0.01%	3351
2016 Q3	$1.3M	Hold	185,294	–	–	﹤0.01%	3205
2016 Q2	$2.84M	Hold	185,294	–	–	﹤0.01%	2912
2016 Q1	$2.89M	Hold	185,294	–	–	﹤0.01%	2895
2015 Q4	$2.27M	Hold	185,294	–	–	﹤0.01%	3068
2015 Q3	$2.37M	Sell	185,294 -747	-0.4%	-$9.43K	﹤0.01%	3059
2015 Q2	$2.25M	Sell	186,041 -41,571	-18%	-$570K	﹤0.01%	3072
2015 Q1	$3.01M	Buy	227,612 +2,974	+1%	+$40.1K	﹤0.01%	2942
2014 Q4	$3.19M	Buy	224,638 +900	+0.4%	+$15.6K	﹤0.01%	2916
2014 Q3	$6.12M	Buy	223,738 +8,543	+4%	+$260K	﹤0.01%	2597
2014 Q2	$8.66M	Buy	215,195 +8,872	+4%	+$328K	﹤0.01%	2520
2014 Q1	$7.94M	Sell	206,323 -18,146	-8%	-$641K	﹤0.01%	2561
2013 Q4	$7.64M	Buy	224,469 +30,231	+16%	+$803K	﹤0.01%	2575
2013 Q3	$3.7M	Sell	194,238 -3,144	-2%	-$55K	﹤0.01%	2861
2013 Q2	$3.05M	Buy	+197,382	New	+$4.17M	﹤0.01%	2900

Other funds holding FLNA

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ZIM

Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Institutional Trust's FLNA Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Filana Therapeutics (FLNA) stake by 8.1% in Q4 2016, buying an estimated $70K and bringing the position to 200,380 shares worth $800K. The position accounts for ﹤0.01% of the portfolio, ranked #3351.

BlackRock Institutional Trust first reported a position in FLNA in Q2 2013 and has held it in 15 quarters since. The position peaked at $8.66M in Q2 2014. 46 funds tracked by Wall St. Rank hold FLNA as of Q4 2016.

BlackRock Institutional Trust held 200,380 shares of Filana Therapeutics worth $800K as of Q4 2016.
BlackRock Institutional Trust bought 15,086 Filana Therapeutics shares in Q4 2016, an estimated $70K.
Filana Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3351 holding.
BlackRock Institutional Trust first reported a position in Filana Therapeutics in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Filana Therapeutics position peaked at $8.66M in Q2 2014.
46 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.